Metraipolis › archive › dc_3fa71daef6e0
Duration of DKA and Insulin Use in People with and Without SGLT2 Inhibitor Medications — Europe PMC PMID:40843859
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40843859
- DOI
- 10.3390/medicines12030021
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T12:56:51.813Z
- SHA-256 of the archived text
8b23f2feb39da1227f69e2728a00b3d70bfc7af654ed69148ddbdd832e00a967- Stable URL of this page
https://metraipolis.com/documento/dc_3fa71daef6e0
How to cite
Duration of DKA and Insulin Use in People with and Without SGLT2 Inhibitor Medications — Europe PMC PMID:40843859 — Europe PMC (en), https://europepmc.org/article/MED/40843859 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3fa71daef6e0 (Metraipolis archive dc_3fa71daef6e0, sha256 8b23f2feb39da1227f69e2728a00b3d70bfc7af654ed69148ddbdd832e00a967)
BibTeX
@misc{dc3fa71daef6e0,
title = {Duration of DKA and Insulin Use in People with and Without SGLT2 Inhibitor Medications — Europe PMC PMID:40843859},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40843859},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3fa71daef6e0; sha256 8b23f2feb39da1227f69e2728a00b3d70bfc7af654ed69148ddbdd832e00a967},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40843859. Agents can read the archived copy with the MCP tool read_document.